Amphastar Pharmaceuticals, Inc. (AMPH) News
Track canonical SquawkNews coverage tagged to AMPH, Amphastar Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Amphastar strategy targets branded and biosimilar growth through 2027
Management outlined a strategy centered on branded and complex generics, with BAQSIMI and new biosimilars aimed to drive near-term growth. Operational improvements and pipeline expansion target margin gains and revenue d
EQUITY | Sep 08, 2026, 09:57 PM UTC
M
AMPH strategy targets BAQSIMI and pipeline launches through 2026
AMPH management outlined a branded and complex generics strategy, citing BAQSIMI and new pipeline launches for mid to high single-digit revenue growth through 2026. Operational improvements and targeted R&D investments a
EQUITY | Sep 08, 2026, 09:32 PM UTC
L
AMPH: Robust R&D and a proprietary-focused pipeline drive growth, anchored by BAQSIMI® and Primatene MIST®
A fully integrated model and strong R&D investment have driven robust revenue and margin growth, with a pipeline shifting toward proprietary and biosimilar products. Key assets like BAQSIMI® and Primatene MIST® anchor co
EQUITY | Sep 08, 2026, 12:21 PM UTC
L
AMPH - Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
AMPH - Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
EQUITY | Sep 01, 2026, 10:01 AM UTC
L
AMPH AMPH - Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026
AMPH AMPH - Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026
EARNINGS | Jul 29, 2026, 10:00 AM UTC
L
Amphastar Unit Receives US FDA Warning Letter on Violations at California Facility
() -- Amphastar Pharmaceuticals (AMPH) unit International Medication Systems has received a warning letter from the US Food and Drug Administration on violations at its drug manufacturing facility in South El Monte, Cali
REGULATION | Jul 08, 2026, 11:04 AM UTC
L
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over
EQUITY | Jul 02, 2026, 01:18 PM UTC
H
Crude Oil Gains 2%; Comcast Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.44% to 52,105.66 while the NASDAQ rose 1.33% to 25,634.54. The S&P 500 also rose, gai
CENTRAL_BANK | Jun 29, 2026, 04:30 PM UTC